Diagonal Bio expands its testing panel for horses with EHV-5 detection
Diagonal Bio AB (publ) ("Diagonal Bio" or the "Company") announces the expansion of its equine diagnostic testing panel to include the detection of Equine Herpesvirus type 5 (EHV-5), following the recommendation of Daniel Redén – Diagonal Bio’s marketing partner and a renowned horse trainer. Diagonal Bio successfully developed, tested, and validated in-house the EHV-5 detection capability within three weeks.Diagonal Bio announced on 3rd October 2024 that horse trainer Daniel Redén from StallZet will conduct a pilot using the LAMPlify® platform to test for equine viruses. This collaboration
Read original